Challenges of Prevention for a Sustainable Personalized Medicine

The development and implementation of the approaches of personalized medicine for disease prevention are still at infancy, although preventive activities in healthcare represent a key pillar to guarantee health system sustainability. There is an increasing interest in finding informative markers that indicate the disease risk before the manifestation of the disease (primary prevention) or for early disease detection (secondary prevention). Recently, the systematic collection and study of clinical phenotypes and biomarkers consented to the advance of Rehabilomics in tertiary prevention. It consents to identify relevant molecular and physiological factors that can be linked to plasticity, treatment response, and natural recovery. Implementation of these approaches would open avenues to identify people at high risk and enable new preventive lifestyle interventions or early treatments targeted to their individual genomic profile, personalizing prevention and rehabilitation. The integration of personalized medicine into prevention may benefit citizens, patients, healthcare professionals, healthcare authorities, and industry, and ultimately will seek to contribute to better health and quality of life for Europe's citizens.

Automated summary

The current development of personalized medicine in disease prevention is still in its infancy, with a focus on identifying informative markers for disease risk before manifestation or early detection. Implementation of personalized medicine could lead to new preventive measures or early treatments targeted to high-risk individuals, enabling personalized prevention and rehabilitation. Integration of personalized medicine into prevention aims to benefit citizens, patients, healthcare professionals, healthcare authorities, and industry, ultimately contributing to better health and quality of life.